Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04235660 · ClinicalTrials.gov registry record · NA
Y90 Radiation Segmentectomy vs SBRT for HCC
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04235660: Clinical Trial NA study, sponsored by Indiana University.
NCT04235660 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04235660, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The proposed study is a single site, prospective, randomized pilot study to assess the feasibility of recruitment of patients into a trial evaluating the efficacy and tolerability of selective transarterial Y90 radioembolization (radiation segmentectomy) versus stereotactic body radiation therapy (SBRT) for solitary early stage (≤ 3cm) hepatocellular carcinoma (HCC).
Primary Outcome
Feasibility of recruitment will be measured by evaluating the proportion of patients enrolled versus those approached for the study after they have been determined to be a candidate.
Interventions
- RADIATION Stereotactic Body Radiation Therapy
- RADIATION Yttrium-90 Radiation Segmentectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-07-22 |
| Est. Completion | 2022-03-08 |
| Phase | NA |
Why NCT04235660 stopped before completion
NCT04235660 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Stereotactic Body Radiation Therapy is the first listed.
NCT04235660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04235660 about?
NCT04235660 is a clinical study titled "Y90 Radiation Segmentectomy vs SBRT for HCC". The proposed study is a single site, prospective, randomized pilot study to assess the feasibility of recruitment of patients into a trial evaluating the efficacy and tolerability of selective transarterial Y90 radioembolization (radiation segmentectomy) versus stereotactic body radiation therapy (S...
What is the current status of trial NCT04235660?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-07-22. Estimated completion is 2022-03-08.
What interventions are being tested in trial NCT04235660?
The interventions under investigation include: Stereotactic Body Radiation Therapy (RADIATION), Yttrium-90 Radiation Segmentectomy (RADIATION).
Who is sponsoring clinical trial NCT04235660?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04235660's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI